Literature DB >> 24029471

Differential immunoregulation in successful oocyte donation pregnancies compared with naturally conceived pregnancies.

Marie-Louise P van der Hoorn1, Angela van Egmond2, Godelieve M J S Swings2, Els van Beelen2, Carin van der Keur2, Irene Tirado-González3, Sandra M Blois3, S Ananth Karumanchi4, Diana W Bianchi5, Frans H J Claas2, Sicco A Scherjon6.   

Abstract

In oocyte donation (OD) pregnancies, there is a higher level of antigenic dissimilarity between mother and fetus compared with naturally conceived (NC) pregnancies. We hypothesize that a higher degree and/or a different type of immunoregulation is necessary to maintain an uncomplicated OD pregnancy. Different immunological aspects of successful OD pregnancies (n=28) were compared with those of NC pregnancies (n=51), and non-donor IVF (n=20) pregnancies. Maternal peripheral blood mononuclear cells (mPBMCs) were characterized by flow cytometry; the outcome correlated with the number of mother-child HLA mismatches. The fetus-specific alloreactivity of mPBMCs was measured in a mixed lymphocyte reaction. The percentages of CD4(+)CD25(bright) and CD4(+)CD25(dim) cells were higher in mPBMCs of OD and IVF pregnancies compared with NC pregnancies. The percentage of CD4(+)CD25(dim) cells in mPBMCs of OD pregnancies correlated positively with the number of HLA mismatches. Functional studies showed a lower proliferative response to umbilical cord blood by mPBMCs in OD pregnancies. In conclusion, we found a higher degree of peripheral immunoregulation in OD and IVF pregnancies compared with NC pregnancies. A higher number of HLA mismatches in successful OD pregnancies leads to increased percentages of activated T cells in peripheral blood, but not to a higher alloreactivity to the fetus. These studies show that immunoregulation in OD pregnancy is different from that in NC pregnancies. The antigenic dissimilarity in OD pregnancies may play a role in the pathophysiology of preeclampsia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Human; Immunology; In vitro fertilization; Oocyte donor; Pregnancy; Reproductive immunology; T cells; Transplantation

Mesh:

Substances:

Year:  2013        PMID: 24029471     DOI: 10.1016/j.jri.2013.08.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  9 in total

Review 1.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

2.  Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology.

Authors:  Sherri Jackson; Connie Hong; Erica T Wang; Carolyn Alexander; Kimberly D Gregory; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2014-10-25       Impact factor: 7.329

3.  Multifoetal gestations mediate the effect of in vitro fertilisation (IVF) on ischaemic placental disease in autologous oocyte IVF more than donor oocyte IVF.

Authors:  Anna M Modest; Louisa H Smith; Thomas L Toth; Ai-Ris Y Collier; Michele R Hacker
Journal:  Paediatr Perinat Epidemiol       Date:  2022-01-04       Impact factor: 3.980

4.  Uncomplicated oocyte donation pregnancies display an elevated CD163-positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches.

Authors:  Xuezi Tian; Kaveri T S Aiyer; Johanna M Kapsenberg; Dave L Roelen; Marie-Louise van der Hoorn; Michael Eikmans
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

5.  Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden.

Authors:  Evangelia Elenis; Gunilla Sydsjö; Alkistis Skalkidou; Claudia Lampic; Agneta Skoog Svanberg
Journal:  BMC Pediatr       Date:  2016-10-21       Impact factor: 2.125

6.  Reactive Species Interactome Alterations in Oocyte Donation Pregnancies in the Absence and Presence of Pre-Eclampsia.

Authors:  Manon Bos; Mirthe H Schoots; Bernadette O Fernandez; Monika Mikus-Lelinska; Laurie C Lau; Michael Eikmans; Harry van Goor; Sanne J Gordijn; Andreas Pasch; Martin Feelisch; Marie-Louise P van der Hoorn
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

7.  Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study).

Authors:  Kim van Bentem; Eileen Lashley; Manon Bos; Michael Eikmans; Sebastiaan Heidt; Frans Claas; Saskia le Cessie; Marie-Louise van der Hoorn
Journal:  BMJ Open       Date:  2019-07-24       Impact factor: 2.692

8.  What are the Predictive Factors for Preeclampsia in Oocyte Recipients?

Authors:  Céline Pimentel; Duros Solene; Jaffre Frédérique; Bouzille Guillaume; Leveque Jean; Le Lous Maëla
Journal:  J Hum Reprod Sci       Date:  2019-12-17

9.  The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved during In Vitro Fertilization and Egg Donation Pregnancies.

Authors:  Alicia Martínez-Varea; Begoña Pellicer; Vicente Serra; David Hervás-Marín; Alicia Martínez-Romero; José Bellver; Alfredo Perales-Marín; Antonio Pellicer
Journal:  J Immunol Res       Date:  2015-08-09       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.